Quarterly Earnings Trend Analysis

The December quarter has seen a marked improvement in the proportion of companies reporting positive earnings, rising to 54.0% from 43.0% in September 2025 and 40.0% in June 2025. This upward trajectory suggests a gradual recovery in corporate profitability after a subdued first half of the fiscal year. The March 2025 quarter had a slightly higher positive result ratio of 44.0%, but the current quarter’s 54.0% represents a meaningful improvement in earnings momentum.

Breaking down by market capitalisation, mid-cap stocks have emerged as the strongest performers with 61.0% reporting positive results. Small caps follow closely with 56.0%, while large caps lag behind at 38.0%. This divergence highlights the resilience and growth potential of mid-sized companies in the current economic environment, possibly benefiting from niche market positioning and operational agility.

Sectoral and Company Highlights

Among large caps, Piramal Finance has stood out with robust earnings, although the sector classification remains unspecified. Mid-cap companies have been led by Laurus Labs, a key player in Pharmaceuticals & Biotechnology, which has delivered an outstanding financial performance for the quarter ended December 2025.

Laurus Labs reported a profit before tax (PBT) excluding other income of ₹320.80 crores, reflecting a staggering growth of 164.56% year-on-year. Its profit after tax (PAT) surged by 172.7% to ₹251.66 crores. Net sales rose 25.67% to ₹1,778.29 crores, marking the highest quarterly sales in the company’s history. Operating profit to interest ratio reached an impressive 12.38 times, underscoring strong operational efficiency and manageable debt levels. The company’s debt-equity ratio stood at a low 0.46 times, indicating a conservative capital structure.

Small caps have been led by Indo Thai Securities in the Capital Markets sector, while micro caps such as String Metaverse (Paper, Forest & Jute Products) and Sera Investments (Non-Banking Financial Company) have also delivered top results, signalling pockets of strength in niche segments.

In-Depth Look at Laurus Labs’ Exceptional Quarter

Laurus Labs’ performance in the December 2025 quarter is a standout example of mid-cap strength. The company’s PBT excluding other income at ₹320.80 crores is the highest recorded, reflecting a 164.56% increase compared to the same quarter last year. PAT of ₹251.66 crores also marks a record high, growing 172.7% year-on-year. This surge is supported by a 25.67% increase in net sales to ₹1,778.29 crores, the highest quarterly sales figure in the company’s history.

Operating profit before depreciation, interest, and tax (PBDIT) reached ₹480.21 crores, the highest level to date, with an operating profit to net sales ratio of 27.00%, indicating strong margin expansion. The operating profit to interest ratio of 12.38 times highlights the company’s ability to comfortably service its debt, while the low debt-equity ratio of 0.46 times reflects prudent financial management.

These metrics collectively demonstrate Laurus Labs’ robust operational performance and financial health, justifying its recent mild bullish rating upgrade from a previously bullish stance on 20 January 2026 at ₹1,035.00 per share. The company’s earnings quality and growth trajectory position it favourably within the Pharmaceuticals & Biotechnology sector.

Large Cap Earnings: A Mixed Bag

Large-cap companies have reported a relatively muted earnings season, with only 38.0% posting positive results. While Piramal Finance has delivered strong numbers, the overall large-cap segment appears to be facing headwinds, possibly due to macroeconomic challenges and sector-specific pressures. Investors may need to exercise selectivity within this segment, focusing on companies with resilient business models and strong balance sheets.

Small and Micro Cap Resilience

Small and micro-cap stocks continue to show resilience, with 56.0% and notable performers such as Indo Thai Securities and String Metaverse leading the charge. These companies often benefit from niche market opportunities and less direct exposure to global economic uncertainties. Sera Investments, a micro-cap NBFC, also posted impressive results, underscoring the potential for growth in the financial services space outside the traditional banking sector.

Upcoming Earnings to Watch

Investors should keep an eye on upcoming results from key companies such as Avantel Ltd, Axis Bank Ltd, and CG Power & Industrial Solutions Ltd, scheduled for release between 25 and 27 January 2026. These results could provide further clarity on sectoral trends and market sentiment heading into the new fiscal quarter.

Conclusion: Earnings Season Reflects Gradual Recovery with Mid Caps in Focus

The December 2025 quarterly earnings season reveals a cautiously optimistic picture for the Indian equity markets. The rise in positive results to 54.0% and the strong showing from mid-cap companies like Laurus Labs suggest improving corporate profitability and operational efficiencies. However, the subdued performance of large caps indicates that challenges remain for some of the market’s heavyweight constituents.

Sectoral leadership from Pharmaceuticals & Biotechnology and select NBFCs highlights areas of growth and investor interest. Meanwhile, small and micro caps continue to offer opportunities for discerning investors seeking growth beyond the mainstream large-cap universe.

Overall, the earnings season underscores the importance of stock selection and sectoral analysis in navigating the evolving market landscape as India’s economy continues its recovery trajectory.

Unlock special upgrade rates for a limited period. Start Saving Now →